Camp4 Therapeutics Corporation
CAMP
$2.65
-$0.60-18.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -51.78M | -51.77M | -51.79M | -51.50M | -49.71M |
| Total Depreciation and Amortization | 1.69M | 1.68M | 1.70M | 1.71M | 1.73M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.17M | 6.02M | 5.86M | 5.67M | 4.74M |
| Change in Net Operating Assets | -1.68M | -4.64M | -1.33M | -1.94M | 335.00K |
| Cash from Operations | -45.61M | -48.71M | -45.56M | -46.06M | -42.92M |
| Capital Expenditure | -542.00K | -705.00K | -441.00K | -421.00K | -628.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -542.00K | -705.00K | -441.00K | -421.00K | -628.00K |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -495.00K | -771.00K | -824.00K | -849.00K | -848.00K |
| Issuance of Common Stock | 76.46M | 76.46M | 76.47M | 206.00K | 176.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.37M | -3.98M | -3.98M | -820.00K | -608.00K |
| Cash from Financing | 72.60M | 71.71M | 71.66M | -1.46M | -1.28M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.45M | 22.30M | 25.66M | -47.94M | -44.83M |